Artichoke Leaf Extract for Indigestion: One Trial and Its Limits

An artichoke supplement label may cite a six-week trial without explaining what its scores mean. The study concerns a specific leaf extract for functional dyspepsia. Its findings need the preparation and the measured outcome attached before they can inform a purchase.

What the six-week trial measured

Published in 2003, the randomized, double-blind trial¹ enrolled 247 patients with functional dyspepsia. The analysis included 244: 129 assigned to artichoke leaf extract and 115 to placebo. The active regimen was two 320-milligram units three times daily, totaling 1,920 milligrams of extract per day.¹

The primary outcome added together weekly patient ratings of overall symptom change on a four-point scale. The cumulative improvement score averaged 8.3 with extract and 6.7 with placebo, a statistically significant difference. Disease-specific quality of life also improved more with extract.¹

Those scores are not percentages relieved or the number of symptom-free days. Both groups improved, with a larger average improvement in the extract group.¹

We could read the original published abstract and author affiliations, rather than the full paper. One author listed Lichtwer Pharma AG. The dose above describes the trial, rather than a plan for selecting or taking a supplement.¹

Why Cochrane called the evidence low certainty

The 2023 Cochrane review based its artichoke-only assessment on that one study with 244 analyzed participants. It found a small symptom benefit, with a standardized mean difference of −0.34, and a small quality-of-life benefit. The reviewers rated the evidence low certainty because of unclear risk of bias and imprecision.²

For adverse events, the risk ratio was 1.44, with a 95% confidence interval of 0.84–2.44. That interval includes both fewer and more events with extract. It cannot establish equal safety or rule out a meaningful increase.²

Repeating the study in a review does not make it an independent replication. The review helps judge the existing experiment’s strengths and limitations.

Our ginger research article covers a separate ginger-and-artichoke combination. A result for that mixture cannot identify artichoke’s individual contribution.

European traditional-use guidance is a separate assessment

The European Medicines Agency’s³ public summary describes artichoke leaf medicines for digestive complaints such as fullness, bloating and flatulence. Its conclusion rests on traditional use, meaning long-standing use with plausible effectiveness despite insufficient clinical-trial evidence. That EU assessment should not be read as proof that every supplement sold elsewhere has demonstrated benefit.³

An official addendum adopted in January 2025, reviewing evidence through September 2024, found no new information requiring revision of the monograph. It did not introduce a new digestive indication or dose.⁴

Check the restrictions before treating it as a digestive aid

The posted EU monograph lists these contraindications:⁵

• Allergy to artichoke’s active substance or plants in the Asteraceae family.
• Bile-duct obstruction, cholangitis, liver disease, gallstones and other biliary disorders requiring medical supervision and advice.

It does not recommend use during pregnancy or breastfeeding because safety has not been established. Reported unwanted effects include slight diarrhea with abdominal spasm, nausea, heartburn and allergic reactions; their frequency is unknown.⁵

The monograph also says to consult a doctor or qualified practitioner if symptoms persist beyond two weeks while using the medicine. That instruction is not a reason to wait two weeks when warning symptoms occur.⁵

Give persistent symptoms an assessment

Indigestion can involve upper-abdominal discomfort, fullness after little food, bloating or nausea. NIDDK⁶ advises seeing a doctor if it does not improve. Difficulty or pain with swallowing, bloody vomit, black tar-like stools, severe constant abdominal pain or unintended weight loss require prompt medical attention.⁶

Bring the product label to the appointment, along with the timing of symptoms and any medicines or supplements already used. Ask which diagnosis the treatment is meant to address and whether the preparation has evidence for that purpose.

Chapter 11 of Bloated by Dinner, “Week 1: Start the Clock,” describes logging meal times, symptoms, bowel movements, medicines and supplements. Those entries can show the pattern for a clinician without assuming an extract treats its cause.